Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach

Abstract Background It is controversial whether or not total thyroidectomy followed by radioactive iodine ablation (RAI-a) (30 mCi = 1.1 GBq) is mandatory in intermediate-risk patients with lateral neck lymph node metastasis (cN1b). Methods This retrospective observational study enrolled PTC patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Kiyomi Horiuchi, Yuki Yamanashi, Tomoyoshi Nakai, Juro Yanagida, Yusaku Yoshida, Yoko Omi, Takahiro Okamoto
Format: Article
Language:English
Published: BMC 2025-07-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-025-03912-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849768987964997632
author Kiyomi Horiuchi
Yuki Yamanashi
Tomoyoshi Nakai
Juro Yanagida
Yusaku Yoshida
Yoko Omi
Takahiro Okamoto
author_facet Kiyomi Horiuchi
Yuki Yamanashi
Tomoyoshi Nakai
Juro Yanagida
Yusaku Yoshida
Yoko Omi
Takahiro Okamoto
author_sort Kiyomi Horiuchi
collection DOAJ
description Abstract Background It is controversial whether or not total thyroidectomy followed by radioactive iodine ablation (RAI-a) (30 mCi = 1.1 GBq) is mandatory in intermediate-risk patients with lateral neck lymph node metastasis (cN1b). Methods This retrospective observational study enrolled PTC patients classified preoperatively as the intermediate-risk with cN1b from January 2010 to December 2017 according to the guidelines for thyroid tumors of the Japanese Association of Endocrine Surgeons (JAES) since 2009. We analyzed recurrence-free survival (RFS) rates estimated by the Kaplan–Meier method in the patients classified into three groups: 1) total thyroidectomy (TTx) followed by lateral neck lymph node dissection (LLND) with RAI-a, 2) TTx + LLND without RAI-a, 3) hemithyroidectomy + LLND. In addition, propensity score analysis adjusted by clinical parameters was performed. Results Two hundred eighty-eight patients with intermediate-risk PTC were identified. Among them, 87 patients with cN1b were analyzed. Five-year RFS rates in 1), 2), and 3) groups were 85.0%, 100%, and 90.9%, respectively. The analysis of 1) and 2) groups by propensity score matching revealed 5-yr RFS rates of 84.1% and 100%, respectively (p < 0.0432). Conclusions There was no evidence to support the use of 30 mCi (1.1GBq) radioactive iodine postoperatively to prevent recurrence in intermediate-risk PTC patients with cN1b.
format Article
id doaj-art-d88061cda50244f9bbebd95bea21e10b
institution DOAJ
issn 1477-7819
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj-art-d88061cda50244f9bbebd95bea21e10b2025-08-20T03:03:37ZengBMCWorld Journal of Surgical Oncology1477-78192025-07-012311810.1186/s12957-025-03912-0Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approachKiyomi Horiuchi0Yuki Yamanashi1Tomoyoshi Nakai2Juro Yanagida3Yusaku Yoshida4Yoko Omi5Takahiro Okamoto6Department of Endocrine Surgery, Tokyo Women’s Medical UniversityDepartment of Endocrine Surgery, Tokyo Women’s Medical UniversityDepartment of Endocrine Surgery, Tokyo Women’s Medical UniversityDepartment of Endocrine Surgery, Tokyo Women’s Medical UniversityDepartment of Endocrine Surgery, Tokyo Women’s Medical UniversityDepartment of Endocrine Surgery, Tokyo Women’s Medical UniversityDepartment of Endocrine Surgery, Tokyo Women’s Medical UniversityAbstract Background It is controversial whether or not total thyroidectomy followed by radioactive iodine ablation (RAI-a) (30 mCi = 1.1 GBq) is mandatory in intermediate-risk patients with lateral neck lymph node metastasis (cN1b). Methods This retrospective observational study enrolled PTC patients classified preoperatively as the intermediate-risk with cN1b from January 2010 to December 2017 according to the guidelines for thyroid tumors of the Japanese Association of Endocrine Surgeons (JAES) since 2009. We analyzed recurrence-free survival (RFS) rates estimated by the Kaplan–Meier method in the patients classified into three groups: 1) total thyroidectomy (TTx) followed by lateral neck lymph node dissection (LLND) with RAI-a, 2) TTx + LLND without RAI-a, 3) hemithyroidectomy + LLND. In addition, propensity score analysis adjusted by clinical parameters was performed. Results Two hundred eighty-eight patients with intermediate-risk PTC were identified. Among them, 87 patients with cN1b were analyzed. Five-year RFS rates in 1), 2), and 3) groups were 85.0%, 100%, and 90.9%, respectively. The analysis of 1) and 2) groups by propensity score matching revealed 5-yr RFS rates of 84.1% and 100%, respectively (p < 0.0432). Conclusions There was no evidence to support the use of 30 mCi (1.1GBq) radioactive iodine postoperatively to prevent recurrence in intermediate-risk PTC patients with cN1b.https://doi.org/10.1186/s12957-025-03912-0Papillary thyroid cancerIntermediate riskRadioactive iodine ablationThyroidectomy
spellingShingle Kiyomi Horiuchi
Yuki Yamanashi
Tomoyoshi Nakai
Juro Yanagida
Yusaku Yoshida
Yoko Omi
Takahiro Okamoto
Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
World Journal of Surgical Oncology
Papillary thyroid cancer
Intermediate risk
Radioactive iodine ablation
Thyroidectomy
title Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
title_full Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
title_fullStr Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
title_full_unstemmed Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
title_short Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
title_sort impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate risk patients with lateral neck lymph node metastasis a retrospective and tentative real world approach
topic Papillary thyroid cancer
Intermediate risk
Radioactive iodine ablation
Thyroidectomy
url https://doi.org/10.1186/s12957-025-03912-0
work_keys_str_mv AT kiyomihoriuchi impactofextentthyroidectomyandradioactiveiodineablationfordiseasefreesurvivalintheintermediateriskpatientswithlateralnecklymphnodemetastasisaretrospectiveandtentativerealworldapproach
AT yukiyamanashi impactofextentthyroidectomyandradioactiveiodineablationfordiseasefreesurvivalintheintermediateriskpatientswithlateralnecklymphnodemetastasisaretrospectiveandtentativerealworldapproach
AT tomoyoshinakai impactofextentthyroidectomyandradioactiveiodineablationfordiseasefreesurvivalintheintermediateriskpatientswithlateralnecklymphnodemetastasisaretrospectiveandtentativerealworldapproach
AT juroyanagida impactofextentthyroidectomyandradioactiveiodineablationfordiseasefreesurvivalintheintermediateriskpatientswithlateralnecklymphnodemetastasisaretrospectiveandtentativerealworldapproach
AT yusakuyoshida impactofextentthyroidectomyandradioactiveiodineablationfordiseasefreesurvivalintheintermediateriskpatientswithlateralnecklymphnodemetastasisaretrospectiveandtentativerealworldapproach
AT yokoomi impactofextentthyroidectomyandradioactiveiodineablationfordiseasefreesurvivalintheintermediateriskpatientswithlateralnecklymphnodemetastasisaretrospectiveandtentativerealworldapproach
AT takahirookamoto impactofextentthyroidectomyandradioactiveiodineablationfordiseasefreesurvivalintheintermediateriskpatientswithlateralnecklymphnodemetastasisaretrospectiveandtentativerealworldapproach